This course has expired. View available courses.
Haemotology, Oncology
Recognising immune-related adverse reactions to immune checkpoint inhibitors – A guide for Emergency Medicine doctors
Over the last decade, immune checkpoint inhibitors (ICIs) have changed the landscape of cancer treatment, but are associated with immune related adverse reactions (irARs) which can impact a wide variety of body organs or systems. These may manifest at any time during ICI therapy and even long after therapy cessation.
As ICI use is becoming more widespread, emergency medicine doctors are often the first to recognise and diagnose irARs, and need to have a low threshold of suspicion. Early consultation with oncology colleagues, will help avoid the pitfalls of missed irAR diagnosis and suboptimal management.
DURATION
1 hr
PROFESSION
Specialist
# OF CREDITS
1
ACCREDITATION
RACP
EXPIRY DATE
2023-07-22
Over the last decade, immune checkpoint inhibitors (ICIs) have changed the landscape of cancer treatment, but are associated with immune related adverse reactions (irARs) which can impact a wide variety of body organs or systems. These may manifest at any time during ICI therapy and even long after therapy cessation.
As ICI use is becoming more widespread, emergency medicine doctors are often the first to recognise and diagnose irARs, and need to have a low threshold of suspicion. Early consultation with oncology colleagues, will help avoid the pitfalls of missed irAR diagnosis and suboptimal management.
This program is supported by an independent educational grant provided from Bristol-Myers Squibb (Australia) Limited. The content contained in this program, including views and opinions expressed by faculty do not represent those of MDBriefCase or the sponsor.
Faculty
Dr. Megan Lyle
Medical Oncologist
Queensland, Australia
Dr. George Plunkett
Emergency Physician
Victoria, Australia
Learning objectives
Upon completion of this continuing education program participants will be better able to:
- Describe immune checkpoint inhibitors’ mechanisms of action and recognise the broad spectrum and potential severity of immune related adverse reactions (irARs)
- Identify and manage irARs in hospital emergency departments (EDs)
- Appreciate the benefits of multidisciplinary management, including early oncology consultation
- Recognise the pitfalls of missed irAR diagnosis and suboptimal management
Accreditation
This interactive online learning activity is valued at 1 Hour of continuing education with RACP.
Fellows of The Royal Australasian College of Physicians (RACP) can claim CPD credits in MyCPD for participation in this course. www.racp.edu.au/mycpd (log in to MyCPD)
This program has been endorsed by the Clinical Oncology Society of Australia (COSA).
This course is approved for 1 ACEM CPD hour with The Australasian College for Emergency Medicine.
If you are completing this course for ACEM points and hold an ACEM ID, please provide this to us when you complete the course, in the 'Course Evaluation'.
#
of credits: 1
Duration: 1 hr
FAQs & HELP
MDBriefCase Group specializes in accredited, online continuing professional development (CPD) programs, custom tailored for specific international markets and available on a convenient online platform.
All content is developed by leading specialists and peer-reviewed by experts at respected institutions, which keeps more than 280,000 global healthcare professionals at the forefront of the latest evidence and protocols worldwide.
The vast majority of our programs are accredited by one or more respected institutions. We do provide unaccredited content to ensure that healthcare professionals have access to relevant practical resources in addition to accredited learning.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
MDBriefCase Group works with various institutions to provide peer-reviewed, up-to-date accredited content. Our programs and resources are provided via collaboration between medical writers, faculty members, associations, universities and other relevant organizations. The content you were recommended is likely valued by your society or association and is conveniently provided to you free of charge on an MDBriefCase Group platform.
Specific accrediting information (including the accrediting body, along with the type and number of credits) can be found on the “Main” page and/or “Accreditation” page of each program. In order to qualify for accreditation and obtain your certificate, you must successfully complete the requirements listed on the “Accreditation” or “CME Information” pages available in each program.
If you are interested in learning more about supporting one of our programs, please contact us.
If you are interested in working with MDBriefCase Group as a writer or committee member, please contact us.
To access the MDBriefCase Group privacy policy, please click here.
No, registration with MDBriefCase is free!
To access your profile, visit My Profile. If you would like to update the information here don’t forget to hit the ‘save’ button when you are finished. Your profile is where you can control what email communications you receive.
If you have forgotten your password, you can reset your password. To access this page from the Login page, click Forgot password. Enter the email address you registered with and you will receive an email with a link to reset your password.
Please note: if you submitted multiple password resets, only the link on the most recent email is valid.
You can unsubscribe from MDBriefCase Group emails by clicking the unsubscribe button located at the bottom of each of our emails.
